Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACUS: Ultrasound Enhanced Paclitaxel Delivery in CLI
NCT02625740Completed
- Sponsor
- University of Rome Tor Vergata
- Start
- Nov 2013
- Primary completion
- Nov 2014
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
Randomised, single-blind trial of Paclitaxel Micelles for Injection in critical limb ischemia (CLI) (2 arms), sponsored by University of Rome Tor Vergata. Primary endpoints: Freedom from clinically driven target lesion revascularization (TLR) and significant restenosis at 6 months and Number of device and procedure related deaths and major adverse clinical events at 1 month. Started Nov 2013; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02625740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625740.